# OnCo record paper-plotkin-bevacizumab-nf2-nejm-2009 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-plotkin-bevacizumab-nf2-nejm-2009/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-plotkin-bevacizumab-nf2-nejm-2009" ;
  schema:name "Hearing improvement after bevacizumab in patients with neurofibromatosis type 2"@en ;
  schema:description "In a small series of people with NF2 and progressive vestibular schwannomas, the anti-VEGF antibody bevacizumab shrank the tumours in most and, remarkably, improved hearing in more than half, opening the first drug treatment for these tumours."@en ;
  schema:url <https://onco.cc/key-papers/paper-plotkin-bevacizumab-nf2-nejm-2009/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa0902579>, <https://pubmed.ncbi.nlm.nih.gov/19587327/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa0902579> ;
  schema:datePublished "2009"^^xsd:gYear ;
  schema:author "Plotkin SR, Stemmer-Rachamimov AO, Barker FG, et al." ;
  onco:cancers <https://onco.cc/cancers/vestibular-schwannoma/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .